XNCR ▼ -0.2% - Xencor, Inc.
$XNCR - Xencor to Host Webcast to Discuss Results From the Phase 1 Study of XmAb819 in Advanced Clear Cell Renal Cell Carcinoma
19-OCT-2026 07:10 AM ET
Share this post
More filings for $XNCR
XNCR ▼ -3.4% - Xencor, Inc.Sep 2, 2026$XNCR SEC Filing Update (31-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 31, 2026
View full $XNCR filing history →💬 Comments
Loading comments…
Leave a comment